This clinical trial aims to construct and apply a collaborative network database for gastric cancer in Hebei Province, driven by artificial intelligence (AI) technology. The project seeks to integrate clinical data, genomic information, and treatment outcomes from multiple hospitals and research centers within the region. By leveraging advanced AI algorithms, the database will facilitate comprehensive data analysis to identify novel biomarkers, optimize therapeutic strategies, and improve patient outcomes. This initiative will also support real-time data sharing and collaboration among healthcare providers, researchers, and policymakers, ultimately enhancing the overall management and treatment of gastric cancer in Hebei Province.
Study Type
OBSERVATIONAL
Enrollment
30,000
Enter the clinical and related test, examination and treatment information of all gastric cancer patients, and find risk factors that affect the prognosis
Department of General Surgery
Shijiazhuang, Hebei, China
RECRUITING5-year overall survival
5-year overall survival
Time frame: 2025-12-31
5-year recurrence-free survival
5-year recurrence-free survival
Time frame: 2025-12-31
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.